Sun Pharmaceutical Industries Limited
SUNPHARMA
Pozycja w akcjach
#521
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Cena akcji
$19.24
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$46.15B
Zmiana (1 dzień)
-0.97%
Zmiana (1 rok)
0.11%
Kraj
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategoria
Healthcare
Wskaźnik P/B dla Sun Pharmaceutical Industries Limited (SUNPHARMA)
Wskaźnik P/B na dzień October 2026 TTM: 5.04
Według najnowszych raportów finansowych i ceny akcji Sun Pharmaceutical Industries Limited, obecny wskaźnik P/B (TTM) wynosi 5.04. Na koniec 2024 wynosił 6.14.
Historia wskaźnika P/B dla Sun Pharmaceutical Industries Limited od 2004 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 5.04 | -10.62% |
| 2025 | 5.64 | -8.20% |
| 2024 | 6.14 | 45.76% |
| 2023 | 4.21 | -7.85% |
| 2022 | 4.57 | 48.09% |
| 2021 | 3.09 | 65.31% |
| 2020 | 1.87 | -32.70% |
| 2019 | 2.77 | -13.24% |
| 2018 | 3.20 | -29.15% |
| 2017 | 4.51 | -28.16% |
| 2016 | 6.28 | -34.58% |
| 2015 | 9.60 | 49.47% |
| 2014 | 6.43 | 14.27% |
| 2013 | 5.62 | 15.92% |
| 2012 | 4.85 | 0.40% |
| 2011 | 4.83 | 1.93% |
| 2010 | 4.74 | 45.08% |
| 2009 | 3.27 | -33.38% |
| 2008 | 4.91 | -31.48% |
| 2007 | 7.16 | -28.60% |
| 2006 | 10.03 | 31.02% |
| 2005 | 7.65 | 3.32% |
| 2004 | 7.41 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
